Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
78.07 M
About Bioasis Technologies Inc.
Sector
Industry
CEO
Deborah A. Rathjen
Website
Headquarters
New Haven
Founded
2006
FIGI
BBG000VNSZF0
biOasis Technologies, Inc. operates as a biopharmaceutical company. It focuses on research and development for the diagnosis and treatment of neurological disease and disorders such as brain cancers, neurodegenerative diseases, and metabolic disorders. Its products include the Transcend program as its proprietary carrier, p97 and imaging agents across the blood brain barrier. The company was founded by Robin B. Hutchison on November 3, 2006 and is headquartered in New Haven, CT.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of BIOAF is 0.000100 USD — it hasn't changed in the past 24 hours. Watch Bioasis Technologies Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Bioasis Technologies Inc. stocks are traded under the ticker BIOAF.
BIOAF stock has risen by 9.90 K% compared to the previous week, the month change is a 9.90 K% rise, over the last year Bioasis Technologies Inc. has showed a −97.22% decrease.
BIOAF reached its all-time high on Sep 12, 2012 with the price of 2.105000 USD, and its all-time low was 0.000001 USD and was reached on Sep 30, 2024. View more price dynamics on BIOAF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
BIOAF stock is 0.00% volatile and has beta coefficient of 21.56. Track Bioasis Technologies Inc. stock price on the chart and check out the list of the most volatile stocks — is Bioasis Technologies Inc. there?
Today Bioasis Technologies Inc. has the market capitalization of 282.48 K, it has increased by 0.66% over the last week.
Yes, you can track Bioasis Technologies Inc. financials in yearly and quarterly reports right on TradingView.
Bioasis Technologies Inc. is going to release the next earnings report on Jan 17, 2025. Keep track of upcoming events with our Earnings Calendar.
No, BIOAF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BIOAF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Bioasis Technologies Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Bioasis Technologies Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Bioasis Technologies Inc. stock shows the sell signal. See more of Bioasis Technologies Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.